GlassScriptPhysician profile
Jeremiah Pflederer
NPI 1124551932
$15,233.52
in general payments reported to CMS, 2019-2025
7 companies · $283 in 2025
The $283 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $5,293 · 2023: $6,501 · 2024: $3,156 · 2025: $283.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,021 · Food and Beverage: $2,599 · Travel and Lodging: $2,321.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,020.72 |
| Food and Beverage | $2,598.59 |
| Travel and Lodging | $2,321.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $12,446.83 | 2022-2024 | Journey II, Journey, Legion Revision |
| Depuy Synthes Sales INC. | $1,648.88 | 2022-2025 | Velys, Attune, Actis |
| Stryker Corporation | $856.41 | 2022-2025 | Hoffmann, Mako, Triathlon |
| Total Joint Orthopedics, INC. | $127.35 | 2022 | |
| Zimmer Biomet Holdings, INC. | $106.57 | 2023 | Gel-One Cross-Linked Hyaluronate |
| Uoc USA INC | $31.48 | 2022 | |
| Medical Device Business Services, INC. | $16.00 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeremiah Pflederer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.